trending Market Intelligence /marketintelligence/en/news-insights/trending/xsDXj8XSvQuWbk_tsLvaGw2 content esgSubNav
In This List

Agios board member to resign

Video

S&P Capital IQ Pro | Powering Your Edge

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


Agios board member to resign

Lewis Cantley will resign as a director of Agios Pharmaceuticals Inc., effective Dec. 31.

Cantley is resigning due to other commitments and not because of any disagreement with the company on any matter relating to its operations, policies or practices.

Cantley will continue to serve on the company's scientific advisory board.